(Q44094808)

29 November 2017

title

Dose regimen of favipiravir for Ebola virus disease (English)

1 reference

29 November 2017

main subject

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

1 reference

Jeremie Guedj

3

0 references

Xavier de Lamballerie

series ordinal

6

object named as

Xavier de Lamballerie

1 reference

29 November 2017

4

Xavier Anglaret

1 reference

29 November 2017

2

Anne-Marie Taburet

1 reference

29 November 2017

1

France Mentré

1 reference

29 November 2017

Sakoba Keïta

5

1 reference

29 November 2017

Denis Malvy

series ordinal

7

1 reference

29 November 2017

publication date

28 November 2014

1 reference

Lancet Infectious Diseases

29 November 2017

published in

1 reference

29 November 2017

volume

15

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

150-151

1 reference

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2971047-3

7 January 2021

Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2971047-3

7 January 2021

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2971047-3

7 January 2021

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2971047-3

7 January 2021

10.1016/S1473-3099(14)71047-3

Identifiers

DOI

1 reference

29 November 2017

1 reference